Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer

European Journal of Surgical Oncology

Volumn 28, Issue 2, 2002, Pages 165-171

  Muller H ^a  

^a Carl von Hess Hospital   (Germany)

Author keywords

Continuous cisplatin; Induction chemotherapy; Mitomycin; Navelbine; Non small cell lung cancer (NSCLC); Regional chemotherapy; Systemic chemotherapy; Thoracic perfusion

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DEXAMETHASONE; FLUOROURACIL; GRANISETRON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MITOMYCIN; NAVELBINE;

ALOPECIA; ANEMIA; ARTICLE; BONE MARROW DEPRESSION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGITIS; FEVER; HEART ARRHYTHMIA; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MORTALITY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; VOMITING;

EID: 0036491850     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2001.1216     Document Type: Article

References (29)

1. Cancer statistics, 1999
2. Current treatment of unresectable lung cancer
3. Controversies in the nonsurgical treatment of Stage III non-small cell lung cancer
4. Improved survival in Stage III nonsmall cell lung cancer. Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial
5. Hyper-fractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for Stage III non small-cell lung cancer - A randomized study
6. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung cancer: An analysis of a randomized trial in 353 patients
7. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a Phase III trial in regionally, advanced unresectable non-small cell lung cancer
8. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
9. Phage III trial of neo-adjuvant chemotherapy (NCT) in resectable stage I (except TI No), II, IIIa non-small cell lung cancer (NSCLC): The French experience
10. Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Soan-Kettering experience with 136 patients
11. Randomized trial of neoadjuvant therapy for lung cancer: Interim analysis
12. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer
13. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
14. Hemodynamic changes during a new procedure for regional chemotherapy involving occlusion of the thoracic aorta and inferior vena cava
15. Stopflow in mediastinum and thorax for resistant lymphoma
16. Regional plus systemic chemotherapy - An effective treatment in recurrent Non Small Cell Lung Cancer
17. Isolated lung perfusion with melphalan prolongs survival in a rat model of metastatic pulmonary adenocarcinoma
18. Isolated lung perfusion with doxorubicin reduces cardiac and host toxicities associated with systemic administration
19. Isolated lung perfusion with FUDR is an effective treatment for colorectal adenocarcinorna lung metastases in rats
20. An experimental study of local chemotherapy for metastatic lung tumor - Isolated lung perfusion and pulmonary artery infusion
21. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: Effects on survival and quality of life
22. Induction therapy for non-small cell lung cancer with involved mediastinal nodes in multiple stations
23. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment
24. Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: Importance of pre-treatment mediastinoscopy
25. Cytostatic lung perfusion by use of an enclovascular blood flow occlusion technique
26. Lung perfusion with chemotherapy in patients with unresectable metastatic sarcoma to the lung or diffuse bronchioloalveolar carcinoma
27. Phage III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable Stage III non-small cell lung cancer
28. A phase II study of carboplatin plus gemcitabine in advanced non-small-cell lung cancer (NSCLC): A hoosier oncology group study
29. Second-line chemo-therapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: Report of a phase II trial